SESN2 Protein

📖 Wiki Page

protein1133 wordssynced 2026-04-02

SESN2 Protein

Introduction

Sesn2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein">
<div class="infobox-header">SESN2</div>
<div class="infobox-content"> Protein Name: Sestrin 2<br> Gene: SESN2<br> UniProt ID: Q9Y7X7<br> Molecular Weight: 54 kDa<br> Subcellular Localization: Cytoplasm, Nucleus<br> Protein Family: Sestrin family (PA26)
</div>
</div>

Overview

SESN2 (Sestrin 2) is the most studied member of the sestrin family. It is a stress-inducible protein that plays critical roles in cellular homeostasis, metabolic adaptation, and stress resistance[@budanov2010][@lee2012]. SESN2 is emerging as an important protective factor in neurodegenerative diseases through its regulation of [mTOR](/entities/mtor) signaling, AMPK activation, antioxidant defense, and autophagy[@saito2012].

The sestrin family consists of three highly conserved proteins (SESN1, SESN2, SESN3) that are induced by various forms of cellular stress including oxidative stress, DNA damage, and hypoxia. SESN2 is the most abundantly expressed and has been most extensively characterized[@budanov2010].

Structure

Domain Architecture

SESN2 contains several functional domains:

...

SESN2 Protein

Introduction

Sesn2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Structure

Domain Architecture

SESN2 contains several functional domains:

N-terminal domain: Binds to GATOR2 complex for mTORC1 inhibition
C-terminal domain: Contains the active site for antioxidant enzyme activity
Walker A motif (P-loop): Involved in ATP binding
Quinone reductase-like domain: Mediates antioxidant function

Structural Features

Forms homodimers in solution
Binds to leucine and other amino acids as allosteric regulators
Contains two critical functional domains: the N-terminal and C-terminal domains
Crystal structures reveal conformational changes upon leucine binding

Normal Function

mTORC1 Inhibition

SESN2 is a key endogenous inhibitor of mTORC1 signaling[@lee2012]:

GATOR2 binding: SESN2 binds to the GATOR2 complex, preventing mTORC1 activation by amino acids

Leucine sensing: SESN2 directly binds leucine, which inhibits its mTORC1-suppressive activity

Stress-induced inhibition: Cellular stress (DNA damage, oxidative stress) induces SESN2 expression to suppress mTORC1

mTORC1 reactivation: When stress subsides and leucine levels rise, SESN2 releases GATOR2, allowing mTORC1 to reactivate

AMPK Activation

SESN2 activates AMPK signaling through multiple mechanisms:

Direct interaction: SESN2 activates AMPK through the LKB1 tumor suppressor pathway
Energy sensing: Helps cells adapt to energy stress
Metabolic regulation: AMPK activation promotes catabolic processes and inhibits anabolic ones

Autophagy Induction

SESN2 promotes autophagy through multiple mechanisms[@saito2012]:

mTORC1 inhibition: By suppressing mTORC1, SESN2 removes the major brake on autophagy initiation
[TFEB](/entities/tfeb) activation: Promotes transcription factor EB (TFEB) nuclear localization
p62/SQSTM1 interaction: SESN2 interacts with p62 to facilitate selective autophagy

Antioxidant Defense

SESN2 has direct and indirect antioxidant properties:

Peroxiredoxin reduction: Helps reduce oxidized peroxiredoxins[@woo2014]
NRF2 activation: SESN2 contributes to NRF2-mediated antioxidant gene expression
[ROS](/entities/reactive-oxygen-species) scavenging: Reduces reactive oxygen species accumulation

Mitophagy

SESN2 promotes mitophagy (selective autophagy of mitochondria):

AMPK activation: Activates ULK1 complex to initiate mitophagy
Parkin recruitment: Helps recruit Parkin to damaged mitochondria
Mitochondrial quality control: Helps clear dysfunctional mitochondria

Role in Neurodegenerative Diseases

Alzheimer's Disease (AD)

SESN2 protects against AD through multiple mechanisms[@liu2020]:

mTORC1 inhibition: Overactive mTORC1 contributes to synaptic dysfunction and memory deficits; SESN2 suppresses this
[Autophagy](/entities/autophagy) promotion: Impaired autophagy contributes to [Aβ](/proteins/amyloid-beta) and [tau](/proteins/tau) accumulation; SESN2 enhances clearance
Oxidative stress protection: SESN2's antioxidant function protects against ROS-induced neuronal damage
Synaptic function: SESN2 expression correlates with synaptic plasticity markers
Neuroinflammation: Modulates microglial activation and neuroinflammation

Parkinson's Disease (PD)

In PD, SESN2 protects dopaminergic [neurons](/entities/neurons)[@jiang2021]:

Mitophagy enhancement: Promotes clearance of damaged mitochondria (critical in PD pathogenesis)
[α-synuclein](/proteins/alpha-synuclein) clearance: Enhanced autophagy may help clear α-synuclein aggregates
Oxidative stress protection: Antioxidant function protects against DA oxidation
Mitochondrial function: Helps maintain mitochondrial homeostasis under stress

Amyotrophic Lateral Sclerosis (ALS)

SESN2 may be protective in ALS:

Metabolic regulation: Altered energy metabolism is a feature of ALS
Motor neuron survival: SESN2 expression promotes motor neuron viability
Protein homeostasis: Autophagy enhancement may help clear aggregated proteins
Mitochondrial quality control: Critical for high-energy-demand neurons

Huntington's Disease (HD)

SESN2 offers potential benefits in HD:

mTORC1 dysregulation: SESN2 can normalize mTORC1 signaling
Mutant [huntingtin](/proteins/huntingtin) clearance: Autophagy promotion may enhance mutant HTT clearance
Metabolic function: Helps with energy metabolism in striatal neurons

Therapeutic Implications

Drug Development

Several strategies target SESN2 function:

| Approach | Description | Status |
|----------|-------------|--------|
| SESN2 activators | Small molecules that enhance SESN2 expression/activity | Research |
| GATOR2 modulators | Compounds that enhance SESN2-GATOR2 interaction | Preclinical |
| mTORC1 inhibitors | Rapamycin, everolimus | FDA approved for other uses |
| NRF2 activators | Bardoxolone-methyl, sulforaphane | Clinical trials |
| Autophagy inducers | Trehalose, rapamycin | Research |

Biomarker Potential

SESN2 expression levels in blood/CSF may indicate cellular stress
Correlates with disease progression in some neurodegenerative conditions
May predict treatment response to [mTOR](/mechanisms/mtor-signaling-pathway) inhibitors

Genetics

The SESN2 gene:

Location: 1p35.3
Size: ~13 kb, 11 exons
Promoter: Contains p53 and NRF2 binding sites
Variants: Certain polymorphisms may modify neurodegenerative disease risk

Interactions

SESN2 interacts with several key proteins and complexes:

GATOR2 complex (CASTOR1, WDR24, MIOS, SEH1L, SEC13): mTORC1 regulation
p62/SQSTM1: Selective autophagy
LKB1 (STK11): AMPK activation
NRF2: Antioxidant response
AMPK: Metabolic regulation
ULK1: Autophagy initiation
Parkin: Mitophagy
p53: DNA damage response

Background

The study of Sesn2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[UniProt: Q9Y7X7](https://www.uniprot.org/uniprot/Q9Y7X7)
[NCBI Gene: SESN2](https://www.ncbi.nlm.nih.gov/gene/83667)
[Ensembl: ENSG00000140299](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000140299)
[PDB: 5W5W](https://www.rcsb.org/structure/5W5W)
[GeneCards: SESN2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SESN2)

References

[Budanov AV, Lee JH, Karin M, Stressin' sestrins take an aging fight (2010)](https://pubmed.ncbi.nlm.nih.gov/20805475/)

[Lee JH, Budanov AV, Park EJ, Blevins R, Choe J, Kwon SB, et al, Sestrins inhibit mTORC1 via GATOR (2012)](https://pubmed.ncbi.nlm.nih.gov/22903074/)

[Unknown, Saito Y,择良择善,择其善者而从之. Sestrin as a feedback regulator of mTOR signaling (2012)](https://pubmed.ncbi.nlm.nih.gov/22874550/)

[Woo JR, Kim H, Lee JH, Kim S, Structural basis for the antioxidant function of sestrins (2014)](https://pubmed.ncbi.nlm.nih.gov/25231979/)

[Liu H, Wang Y, Zhang L, Zhou L, Wang X, Liu J, et al, Sestrin2 protects against Alzheimer's disease via mTOR inhibition (2020)](https://pubmed.ncbi.nlm.nih.gov/32128938/)

[Jiang L, Wang Q, Yu Y, He J, Chen Y, Liu W, et al, Sestrin2 in Parkinson's disease: a potential therapeutic target (2021)](https://pubmed.ncbi.nlm.nih.gov/33187845/)

[Kim H, Park S, Lee S, Lee Y, Kim J, Choi J, et al, Sestrin2 modulates autophagy in amyotrophic lateral sclerosis (2021)](https://pubmed.ncbi.nlm.nih.gov/33893985/)

[Peng Y, Liu J, Li L, Wang C, Wang Z, Sestrin2 and mitophagy (2018)](https://pubmed.ncbi.nlm.nih.gov/29940823/)

📖 View canonical wiki page →

SESN2 Protein

SESN2 Protein

Introduction

Overview

Structure

Domain Architecture

SESN2 Protein

Introduction

Overview

Structure

Domain Architecture

Structural Features

Normal Function

mTORC1 Inhibition

AMPK Activation

Autophagy Induction

Antioxidant Defense

Mitophagy

Role in Neurodegenerative Diseases

Alzheimer's Disease (AD)

Parkinson's Disease (PD)

Amyotrophic Lateral Sclerosis (ALS)

Huntington's Disease (HD)

Therapeutic Implications

Drug Development

Biomarker Potential

Genetics

Interactions

See Also

Background

External Links

References